Literature DB >> 7483787

Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.

R W Fulton1, A W Confer, L J Burge, L J Perino, J M d'Offay, M E Payton, R E Mock.   

Abstract

Calves were vaccinated with four different commercial viral vaccines containing bovine herpesvirus-1 (BHV-1), bovine viral diarrhea (BVDV), parainfluenza-3 virus (PI-3V), and bovine respiratory syncytial virus (BRSV) immunogens. For the initial vaccination certain vaccines were given twice (days 0 and 28), whereas other vaccines were given on day 0. The calves received another injection on day 140 with the vaccine originally given on day 0. The sera were collected at days 0, 7, 14, 21, 28, 42, 56, 84, 112, 140, 154, 168, and 196 and assayed for viral neutralizing antibodies. The calves were seronegative to BHV-1, BVDV, and BRSV at the onset of the experiment; however, the calves were PI-3V antibody positive due to prior active infection. The commercial vaccines were: (I) inactivated; (II) modified live virus (MLV); (III) combination of chemically altered live virus, MLV, and inactivated virus; and (IV) combination of inactivated and MLV. Among the vaccine groups there were differences in onset and duration of antibodies as measured by geometric mean titers to each immunogen in postvaccination collection dates compared to day 0 titers; and likewise compared to day 140 titers after revaccination at day 140. There were also differences in antibody titers to the various viruses among the vaccine groups on specific collection dates. All four vaccines induced increased BHV-1 antibodies by day 14 after the initial injection. The antibody titers induced by MLV BHV-1 and the chemically altered BHV-1 vaccines had greater duration than those induced by the inactivated vaccine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483787     DOI: 10.1016/0264-410x(94)00072-u

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus.

Authors:  R W Fulton; C W Purdy; A W Confer; J T Saliki; R W Loan; R E Briggs; L J Burge
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Bovine coronavirus (BCV) infections in transported commingled beef cattle and sole-source ranch calves.

Authors:  Robert W Fulton; Douglas L Step; Jackie Wahrmund; Lurinda J Burge; Mark E Payton; Billy J Cook; Dirk Burken; Chris J Richards; Anthony W Confer
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

3.  Nested reverse transcriptase-polymerase chain reaction (RT-PCR) for typing ruminant pestiviruses: bovine viral diarrhea viruses and border disease virus.

Authors:  R W Fulton; J M d'Offay; J T Saliki; L J Burge; R G Helman; A W Confer; S R Bolin; J F Ridpath
Journal:  Can J Vet Res       Date:  1999-10       Impact factor: 1.310

4.  The associations of viral and mycoplasmal antibody titers with respiratory disease and weight gain in feedlot calves.

Authors:  S W Martin; E Nagy; D Armstrong; S Rosendal
Journal:  Can Vet J       Date:  1999-08       Impact factor: 1.008

5.  Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.

Authors:  R W Fulton; J T Saliki; L J Burge; J M d'Offay; S R Bolin; R K Maes; J C Baker; M L Frey
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 6.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

7.  Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.

Authors:  Robert W Fulton; Julia F Ridpath; Jeremiah T Saliki; Robert E Briggs; Anthony W Confer; Lurinda J Burge; C W Purdy; Raymond W Loan; Glenn C Duff; Mark E Payton
Journal:  Can J Vet Res       Date:  2002-07       Impact factor: 1.310

8.  Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.

Authors:  Luc DesCôteaux; Dominique Cécyre; Johanne Elsener; Guy Beauchamp
Journal:  Can Vet J       Date:  2003-10       Impact factor: 1.008

9.  Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.

Authors:  Lingshu Wang; J Oriol Sunyer; Leonard J Bello
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Authors:  Gaetano Donofrio; Valentina Franceschi; Antonio Capocefalo; Simone Taddei; Chiara Sartori; Sabrina Bonomini; Sandro Cavirani; Clotilde S Cabassi; Cesidio F Flammini
Journal:  Clin Vaccine Immunol       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.